GERRESHEIMER AG (GXI.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:GXI - DE000A0LD6E6 - Common Stock
27.4 EUR
+0.1 (+0.37%)
Overall GXI gets a fundamental rating of 3 out of 10. We evaluated GXI against 22 industry peers in the Life Sciences Tools & Services industry. GXI has a bad profitability rating. Also its financial health evaluation is rather negative. GXI has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
GXI had positive earnings in the past year.
In the past year GXI had a positive cash flow from operations.
In the past 5 years GXI has always been profitable.
In the past 5 years GXI always reported a positive cash flow from operatings.
1.2 Ratios
GXI has a worse Return On Assets (0.50%) than 81.82% of its industry peers.
GXI has a Return On Equity of 1.67%. This is in the lower half of the industry: GXI underperforms 77.27% of its industry peers.
GXI's Return On Invested Capital of 2.79% is on the low side compared to the rest of the industry. GXI is outperformed by 81.82% of its industry peers.
GXI had an Average Return On Invested Capital over the past 3 years of 6.14%. This is below the industry average of 9.70%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| ROIC | 2.79% |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
1.3 Margins
GXI has a worse Profit Margin (1.04%) than 81.82% of its industry peers.
In the last couple of years the Profit Margin of GXI has remained more or less at the same level.
Looking at the Operating Margin, with a value of 5.99%, GXI is doing worse than 81.82% of the companies in the same industry.
GXI's Operating Margin has improved in the last couple of years.
GXI has a worse Gross Margin (26.89%) than 77.27% of its industry peers.
In the last couple of years the Gross Margin of GXI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.99% | ||
| PM (TTM) | 1.04% | ||
| GM | 26.89% |
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GXI is destroying value.
GXI has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, GXI has more shares outstanding
Compared to 1 year ago, GXI has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.96, we must say that GXI is in the distress zone and has some risk of bankruptcy.
GXI has a Altman-Z score of 0.96. This is amonst the worse of the industry: GXI underperforms 81.82% of its industry peers.
A Debt/Equity ratio of 1.22 is on the high side and indicates that GXI has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.22, GXI is doing worse than 68.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.96 |
ROIC/WACC0.33
WACC8.46%
2.3 Liquidity
A Current Ratio of 0.98 indicates that GXI may have some problems paying its short term obligations.
GXI's Current ratio of 0.98 is on the low side compared to the rest of the industry. GXI is outperformed by 77.27% of its industry peers.
A Quick Ratio of 0.52 indicates that GXI may have some problems paying its short term obligations.
The Quick ratio of GXI (0.52) is worse than 72.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.52 |
3. Growth
3.1 Past
The earnings per share for GXI have decreased strongly by -19.08% in the last year.
Measured over the past years, GXI shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.23% on average per year.
GXI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.83%.
GXI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.90% yearly.
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
3.2 Future
GXI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.02% yearly.
The Revenue is expected to grow by 7.40% on average over the next years.
EPS Next Y-33.84%
EPS Next 2Y-15.26%
EPS Next 3Y-4.47%
EPS Next 5Y6.02%
Revenue Next Year13.03%
Revenue Next 2Y8.75%
Revenue Next 3Y7.84%
Revenue Next 5Y7.4%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 7.43 indicates a rather cheap valuation of GXI.
GXI's Price/Earnings ratio is rather cheap when compared to the industry. GXI is cheaper than 100.00% of the companies in the same industry.
GXI is valuated cheaply when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 8.15 indicates a reasonable valuation of GXI.
GXI's Price/Forward Earnings ratio is rather cheap when compared to the industry. GXI is cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.88, GXI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.43 | ||
| Fwd PE | 8.15 |
4.2 Price Multiples
95.45% of the companies in the same industry are more expensive than GXI, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.49 |
4.3 Compensation for Growth
GXI's earnings are expected to decrease with -4.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.26%
EPS Next 3Y-4.47%
5. Dividend
5.1 Amount
GXI has a yearly dividend return of 0.15%, which is pretty low.
Compared to an average industry Dividend Yield of 0.48, GXI has a dividend in line with its industry peers.
With a Dividend Yield of 0.15, GXI pays less dividend than the S&P500 average, which is at 1.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.15% |
5.2 History
The dividend of GXI has a limited annual growth rate of 0.94%.
Dividend Growth(5Y)0.94%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
10.12% of the earnings are spent on dividend by GXI. This is a low number and sustainable payout ratio.
The dividend of GXI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP10.12%
EPS Next 2Y-15.26%
EPS Next 3Y-4.47%
FRA:GXI (1/9/2026, 7:00:00 PM)
27.4
+0.1 (+0.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.9%
Inst Owner ChangeN/A
Ins Owners4.92%
Ins Owner ChangeN/A
Market Cap946.40M
Revenue(TTM)2.25B
Net Income(TTM)23.35M
Analysts65.22
Price Target38.55 (40.69%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.15% |
Yearly Dividend1.32
Dividend Growth(5Y)0.94%
DP10.12%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.39%
Min EPS beat(2)-6.69%
Max EPS beat(2)1.92%
EPS beat(4)3
Avg EPS beat(4)7.96%
Min EPS beat(4)-6.69%
Max EPS beat(4)18.84%
EPS beat(8)5
Avg EPS beat(8)4.68%
EPS beat(12)8
Avg EPS beat(12)3.75%
EPS beat(16)9
Avg EPS beat(16)2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.48%
Min Revenue beat(2)-2.11%
Max Revenue beat(2)-0.85%
Revenue beat(4)0
Avg Revenue beat(4)-1.32%
Min Revenue beat(4)-2.11%
Max Revenue beat(4)-0.72%
Revenue beat(8)1
Avg Revenue beat(8)-0.95%
Revenue beat(12)3
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)-0.5%
PT rev (3m)-37.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-30.91%
EPS NY rev (1m)0%
EPS NY rev (3m)-18.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.83%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-3.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.43 | ||
| Fwd PE | 8.15 | ||
| P/S | 0.42 | ||
| P/FCF | N/A | ||
| P/OCF | 3.73 | ||
| P/B | 0.68 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.49 |
EPS(TTM)3.69
EY13.47%
EPS(NY)3.36
Fwd EY12.27%
FCF(TTM)-2.51
FCFYN/A
OCF(TTM)7.34
OCFY26.8%
SpS65.15
BVpS40.59
TBVpS-8.95
PEG (NY)N/A
PEG (5Y)N/A
Graham Number58.05
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| ROCE | 3.76% | ||
| ROIC | 2.79% | ||
| ROICexc | 2.93% | ||
| ROICexgc | 5.89% | ||
| OM | 5.99% | ||
| PM (TTM) | 1.04% | ||
| GM | 26.89% | ||
| FCFM | N/A |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
ROICexc(3y)6.5%
ROICexc(5y)6.42%
ROICexgc(3y)14.47%
ROICexgc(5y)16.32%
ROCE(3y)8.29%
ROCE(5y)8.2%
ROICexgc growth 3Y-17.1%
ROICexgc growth 5Y-18.13%
ROICexc growth 3Y-1.3%
ROICexc growth 5Y1.06%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
F-Score4
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.4 | ||
| Cap/Depr | 134.54% | ||
| Cap/Sales | 15.12% | ||
| Interest Coverage | 1.65 | ||
| Cash Conversion | 65.42% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.52 | ||
| Altman-Z | 0.96 |
F-Score4
WACC8.46%
ROIC/WACC0.33
Cap/Depr(3y)167.14%
Cap/Depr(5y)152.09%
Cap/Sales(3y)15.92%
Cap/Sales(5y)14.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
EPS Next Y-33.84%
EPS Next 2Y-15.26%
EPS Next 3Y-4.47%
EPS Next 5Y6.02%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
Revenue Next Year13.03%
Revenue Next 2Y8.75%
Revenue Next 3Y7.84%
Revenue Next 5Y7.4%
EBIT growth 1Y-34.26%
EBIT growth 3Y10.54%
EBIT growth 5Y10.8%
EBIT Next Year91.04%
EBIT Next 3Y32.27%
EBIT Next 5Y21.19%
FCF growth 1Y-1073.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.63%
OCF growth 3Y4.26%
OCF growth 5Y4.49%
GERRESHEIMER AG / GXI.DE FAQ
What is the ChartMill fundamental rating of GERRESHEIMER AG (GXI.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to GXI.DE.
What is the valuation status for GXI stock?
ChartMill assigns a valuation rating of 5 / 10 to GERRESHEIMER AG (GXI.DE). This can be considered as Fairly Valued.
How profitable is GERRESHEIMER AG (GXI.DE) stock?
GERRESHEIMER AG (GXI.DE) has a profitability rating of 3 / 10.
What is the expected EPS growth for GERRESHEIMER AG (GXI.DE) stock?
The Earnings per Share (EPS) of GERRESHEIMER AG (GXI.DE) is expected to decline by -33.84% in the next year.
How sustainable is the dividend of GERRESHEIMER AG (GXI.DE) stock?
The dividend rating of GERRESHEIMER AG (GXI.DE) is 4 / 10 and the dividend payout ratio is 10.12%.